A phase II study of TR105 in patients with hepatocellular carcinoma (HCC) who have progressed on sorafenib.

被引：0
|
作者：
Duffy, Austin G. [1 ]
Rahma, Osama E. [1 ]
Ulahannan, Susanna Varkey [1 ]
Fioravanti, Suzanne [1 ]
Venkatesan, Aradhana [1 ]
Turkbey, Ismail B. [1 ]
Choyke, Peter L. [1 ]
Trepel, Jane B. [1 ]
Figg, William Douglas [1 ]
Greten, Tim F. [1 ]
机构：
[1] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15177
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC)
    Ryoo, B-Y.
    Ren, Z.
    Kim, T-Y.
    Pan, H.
    Rau, K-M.
    Choi, H. J.
    Park, J-W.
    Kim, J. H.
    Yen, C-J.
    Kim, B-H.
    Zhou, D.
    Straub, J.
    Zhao, C.
    Qin, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] Phase II trial of sorafenib (S) and capecitabine (C) for hepatocellular carcinoma (HCC) in cirrhotic patients (pts).
    Rojas-Hernandez, Cristhiam Mauricio
    Patt, Yehuda Z.
    Fekrazad, M. Houman
    Steinberg, Kim A.
    Roach, Mary
    Lee, Fa-Chyi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] A phase 2 and biomarker study of sorafenib combined with FOLFOX in patients with advanced hepatocellular carcinoma (HCC).
    Goyal, Lipika
    Zheng, Hui
    Abrams, Thomas Adam
    Miksad, Rebecca A.
    Bullock, Andrea J.
    Allen, Jill N.
    Yurgelun, Matthew B.
    Sheehan, Susan
    Lynch, Patricia
    Afflitto, Anthony James
    Dinicola, Caroline
    Maurer, Jordan Robert
    Reyes, Stephanie
    Knowles, Michelle
    Galway, Aralee
    Clark, Jeffrey W.
    Birnbaum, Emilie
    Khachatryan, Anna
    Duda, Gabriel Dan
    Zhu, Andrew X.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [24] Phase II trial of temsirolimus (TEM) plus sorafenib (SOR) in hepatocellular carcinoma (HCC)
    Kelley, Robin Kate
    Nimeiri, Halla Sayed
    Gordan, John Dozier
    Hwang, Jimmy
    McWhirter, Ryan M.
    Kanakamedala, Advaita
    Atreya, Chloe Evelyn
    Kulik, Laura
    Kircher, Sheetal
    Mulcahy, Mary Frances
    Benson, Al Bowen
    Venook, Alan P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [25] Phase I/II study of everolimus in patients with advanced hepatocellular carcinoma (HCC)
    Blaszkowsky, L. S.
    Abrams, T. A.
    Miksad, R. A.
    Zheng, H.
    Meyerhardt, J. A.
    Schrag, D.
    Kwak, E. L.
    Fuchs, C.
    Ryan, D. P.
    Zhu, A. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Phase II study of single agent perifosine in patients with hepatocellular carcinoma (HCC)
    Campos, L. T.
    Nemunaitis, J.
    Stephenson, J.
    Richards, D.
    Barve, M.
    Gardner, L.
    Niecestro, R.
    Sportelli, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib-A cost-effectiveness analysis
    Shlomai, Amir
    Leshno, Moshe
    Goldstein, Daniel A.
    PLOS ONE, 2018, 13 (11):
  • [28] An international cohort study investigating the impact of age on clinical outcome in patients with hepatocellular carcinoma treated with sorafenib.
    Sharma, Rohini
    Hajiev, Saur
    Aval, Leila Motedayan
    Bettinger, Dominik
    Arizumi, Tadaaki
    Pirisi, Mario
    Rimassa, Lorenza
    Personeni, Nicola
    Pressiani, Tiziana
    Giordano, Laura
    Kudo, Masatoshi
    Thimme, Robert
    Park, Joong-Won
    Taddei, Tamar Hamosh
    Kaplan, David Edward
    Ramaswami, Ramya
    Pinato, David James
    Allara, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Phase III trial of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Cainap, Calin
    Qin, Shukui
    Huang, Wen-Tsung
    Chung, Ik-Joo
    Pan, Hongming
    Cheng, Ying
    Kudo, Masatoshi
    Kang, Yoon-Koo
    Chen, Pei-Jer
    Toh, Han Chong
    Gorbunova, Vera
    Eskens, Ferry
    Qian, Jiang
    McKee, Mark D.
    Ricker, Justin L.
    Carlson, Dawn M.
    El Nowiem, Saied
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [30] Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
    Park, Joong-Won
    Koh, Young Hwan
    Kim, Hyun Beom
    Kim, Hwi Young
    An, Sangbu
    Choi, Joon-Il
    Woo, Sang Myung
    Nam, Byung-Ho
    JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1336 - 1342
12345